Those with p21-positive and p53-negative cancers have significantly higher survival curves in gastric carcinoma [21], whereas the loss of p21 expression along with increased p53 detection is associated with poor prognosis and decreased overall survival in gastric cancer [22]. This evidence concerns the gene TP53 and gastric carcinoma.